Progress in the treatment of adults with acute lymphoblastic leukemia.

Progress in the treatment of adults with acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q37184366
CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemiaRecurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia.A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemiasHigh frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.Comparison of temporal changes in psychological distress after hematopoietic stem cell transplantation among the underlying diseases of Japanese adult patients.High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organizedIntensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40.Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.Defined, serum/feeder-free conditions for expansion and drug screening of primary B-acute lymphoblastic leukemia.Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
P2860

Progress in the treatment of adults with acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q37184366
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
Progress in the treatment of adults with acute lymphoblastic leukemia.
@nl
type
label
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
Progress in the treatment of adults with acute lymphoblastic leukemia.
@nl
prefLabel
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
Progress in the treatment of adults with acute lymphoblastic leukemia.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Progress in the treatment of adults with acute lymphoblastic leukemia.
@en
P2093
P304
P31
P356
10.1097/MOH.0B013E3283034697
P433
P478
P577
P698
P921